Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer

BACKGROUND: Adjuvant endocrine treatment improves survival after estrogen receptor (ER) positive breast cancer. Recurrences occur, and most patients with metastatic breast cancer develop treatment resistance and incurable disease. An influential factor in relation to endocrine treatment resistance i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jögi, Annika, Ehinger, Anna, Hartman, Linda, Alkner, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903737/
https://www.ncbi.nlm.nih.gov/pubmed/31821370
http://dx.doi.org/10.1371/journal.pone.0226150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903737/
https://www.ncbi.nlm.nih.gov/pubmed/31821370
http://dx.doi.org/10.1371/journal.pone.0226150

Ejemplares similares